Antiarrhythmic [EPC]

Antiarrhythmic [EPC] was reported 99591 times

Drugs of the Antiarrhythmic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 769 0.7241
1 INSPIRATORY CAPACITY DECREASED 95 0.3430
2 DEVICE WIRELESS COMMUNICATION ISSUE 72 0.2780
3 APPENDICOLITH 100 0.2584
4 INFUSION SITE DISCHARGE 453 0.2581
5 ANALGESIC THERAPY 69 0.2150
6 LAGOPHTHALMOS 81 0.1980
7 MATERNAL EXPOSURE DURING DELIVERY 194 0.1958
8 DEVICE MAINTENANCE ISSUE 114 0.1939
9 TOXIC ANTERIOR SEGMENT SYNDROME 203 0.1861
10 INFUSION SITE HAEMORRHAGE 581 0.1764
11 INFUSION SITE MASS 177 0.1628
12 INFUSION SITE PRURITUS 472 0.1495
13 INFUSION SITE NODULE 142 0.1478
14 INFUSION SITE IRRITATION 188 0.1463
15 INFUSION SITE BRUISING 313 0.1448
16 INFUSION SITE SWELLING 883 0.1402
17 METHAEMOGLOBINAEMIA 323 0.1394
18 INFUSION SITE WARMTH 163 0.1330
19 INFUSION SITE URTICARIA 88 0.1313
20 INFUSION SITE PAIN 1579 0.1224
21 INFUSION SITE ERYTHEMA 1022 0.1211
22 INFUSION SITE RASH 164 0.1194
23 INFUSION SITE DISCOMFORT 123 0.1186
24 INFUSION SITE DISCOLOURATION 100 0.1136
25 DEVICE INFUSION ISSUE 280 0.1128
26 INFUSION SITE INDURATION 167 0.1126
27 INFUSION SITE INFLAMMATION 73 0.1034
28 PRODUCT ADHESION ISSUE 3520 0.0984
29 INFUSION SITE INFECTION 202 0.0868
30 INFUSION SITE REACTION 247 0.0826
31 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 86 0.0810
32 ANAESTHETIC COMPLICATION 204 0.0759
33 HYPERPARATHYROIDISM SECONDARY 165 0.0658
34 NEPHROGENIC ANAEMIA 297 0.0641
35 CARDIAC ABLATION 105 0.0587
36 CARDIOVERSION 82 0.0587
37 INCORRECT DRUG ADMINISTRATION RATE 245 0.0575
38 KOUNIS SYNDROME 130 0.0572
39 MULTIPLE ALLERGIES 444 0.0566
40 INFUSION SITE EXTRAVASATION 351 0.0563
41 HYPERTHERMIA MALIGNANT 80 0.0537
42 HYPERPHOSPHATAEMIA 113 0.0525
43 INSURANCE ISSUE 737 0.0481
44 APPLICATION SITE DISCOMFORT 83 0.0462
45 SEASONAL ALLERGY 652 0.0460
46 DERMATITIS CONTACT 512 0.0448
47 ESSENTIAL HYPERTENSION 79 0.0431
48 TORSADE DE POINTES 334 0.0425
49 VENTRICULAR TACHYCARDIA 702 0.0425
50 VENTRICULAR FIBRILLATION 469 0.0422
51 BLOOD PHOSPHORUS INCREASED 109 0.0399
52 REBOUND ACID HYPERSECRETION 117 0.0386
53 PULSELESS ELECTRICAL ACTIVITY 147 0.0351
54 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1928 0.0351
55 CORNEAL OEDEMA 78 0.0348
56 ATRIAL FIBRILLATION 3220 0.0330
57 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 109 0.0329
58 ATRIAL FLUTTER 254 0.0318
59 CHRONIC SINUSITIS 116 0.0309
60 OBSTRUCTION 122 0.0305
61 PULSE ABSENT 142 0.0298
62 DEVICE POWER SOURCE ISSUE 86 0.0294
63 STRESS CARDIOMYOPATHY 171 0.0294
64 EAR INFECTION 765 0.0287
65 SUPRAVENTRICULAR EXTRASYSTOLES 97 0.0287
66 SINUSITIS 2929 0.0286
67 CATHETER SITE PAIN 72 0.0277
68 RESPIRATORY TRACT INFECTION 715 0.0274
69 END STAGE RENAL DISEASE 499 0.0273
70 HAEMORRHAGIC ANAEMIA 119 0.0270
71 LUMBAR SPINAL STENOSIS 78 0.0267
72 PURULENT DISCHARGE 114 0.0267
73 ANAPHYLACTIC SHOCK 673 0.0261
74 OTITIS MEDIA 86 0.0260
75 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 160 0.0259
76 POOR VENOUS ACCESS 268 0.0259
77 VENTRICULAR EXTRASYSTOLES 267 0.0257
78 PRODUCT QUALITY ISSUE 3462 0.0255
79 IRON DEFICIENCY 114 0.0253
80 PRODUCT DISTRIBUTION ISSUE 235 0.0253
81 PARAPLEGIA 73 0.0253
82 UPPER RESPIRATORY TRACT INFECTION 1158 0.0250
83 SKIN ABRASION 118 0.0249
84 APPLICATION SITE BURN 119 0.0241
85 VASCULAR DEVICE INFECTION 108 0.0238
86 CARDIOGENIC SHOCK 339 0.0236
87 ARTHRITIS BACTERIAL 96 0.0234
88 STREPTOCOCCAL INFECTION 130 0.0233
89 GENERALISED TONIC-CLONIC SEIZURE 377 0.0228
90 AORTIC STENOSIS 79 0.0227
91 BUNDLE BRANCH BLOCK LEFT 96 0.0226
92 VENTRICULAR ARRHYTHMIA 82 0.0224
93 HYPERVOLAEMIA 109 0.0220
94 INTERVERTEBRAL DISC DEGENERATION 203 0.0219
95 RHINOVIRUS INFECTION 85 0.0218
96 VENTRICULAR HYPOKINESIA 70 0.0218
97 ARTHRITIS INFECTIVE 101 0.0218
98 ELECTROCARDIOGRAM QT PROLONGED 782 0.0217
99 PRODUCT ADMINISTRATION INTERRUPTED 169 0.0215
100 APNOEA 167 0.0214
101 STATUS EPILEPTICUS 241 0.0213
102 HYPOPHOSPHATAEMIA 155 0.0210
103 GASTROENTERITIS VIRAL 377 0.0209
104 SPINAL OSTEOARTHRITIS 183 0.0208
105 ATELECTASIS 198 0.0205
106 TYPE I HYPERSENSITIVITY 72 0.0204
107 EXTRASYSTOLES 142 0.0203
108 MYASTHENIA GRAVIS 163 0.0202
109 PHARYNGITIS STREPTOCOCCAL 218 0.0201
110 SINUS TACHYCARDIA 286 0.0201
111 SKIN INFECTION 225 0.0200
112 RESPIRATORY ACIDOSIS 78 0.0198
113 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 101 0.0197
114 TOOTH INFECTION 259 0.0196
115 SINUS BRADYCARDIA 189 0.0195
116 BRONCHITIS 1423 0.0192
117 PRE-EXISTING CONDITION IMPROVED 120 0.0192
118 MENINGITIS ASEPTIC 86 0.0191
119 BRADYCARDIA 1015 0.0191
120 HYPERLIPIDAEMIA 228 0.0191
121 BLOOD URIC ACID INCREASED 110 0.0190
122 CARDIAC ARREST 1556 0.0188
123 SINUS DISORDER 370 0.0187
124 HAEMODYNAMIC INSTABILITY 141 0.0185
125 WEIGHT FLUCTUATION 193 0.0184
126 TENDERNESS 192 0.0184
127 ANAPHYLACTIC REACTION 1016 0.0184
128 SPINAL CORD COMPRESSION 71 0.0182
129 SKIN LACERATION 198 0.0182
130 GLUCOSE TOLERANCE IMPAIRED 107 0.0181
131 BODY HEIGHT DECREASED 192 0.0179
132 HEART RATE ABNORMAL 100 0.0179
133 HYPOXIA 630 0.0179
134 HORDEOLUM 77 0.0178
135 SPINAL COLUMN STENOSIS 84 0.0178
136 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 90 0.0178
137 PROCTALGIA 114 0.0177
138 EYE INFECTION 200 0.0177
139 APPENDICITIS 164 0.0175
140 GASTROINTESTINAL INFECTION 157 0.0175
141 ANHEDONIA 459 0.0174
142 RENAL INJURY 517 0.0174
143 BACTERIAL INFECTION 320 0.0171
144 UNRESPONSIVE TO STIMULI 440 0.0170
145 BRONCHIECTASIS 114 0.0169
146 NEURALGIA 407 0.0167
147 FOOD POISONING 89 0.0166
148 KIDNEY INFECTION 325 0.0165
149 TOOTH ABSCESS 168 0.0165
150 LIVE BIRTH 138 0.0165
151 INTERVERTEBRAL DISC DISORDER 70 0.0164
152 CHRONIC KIDNEY DISEASE 1245 0.0164
153 MULTI-ORGAN FAILURE 282 0.0163
154 VIRAL INFECTION 540 0.0162
155 HAEMOGLOBIN INCREASED 74 0.0162
156 NYSTAGMUS 86 0.0162
157 DECUBITUS ULCER 132 0.0162
158 SUPRAVENTRICULAR TACHYCARDIA 155 0.0162
159 ABSCESS LIMB 69 0.0162
160 MENTAL STATUS CHANGES 447 0.0161
161 RESPIRATORY SYNCYTIAL VIRUS INFECTION 140 0.0161
162 RHINITIS ALLERGIC 71 0.0159
163 LOWER GASTROINTESTINAL HAEMORRHAGE 117 0.0158
164 CARDIAC PACEMAKER INSERTION 93 0.0156
165 PERIPHERAL VASCULAR DISORDER 80 0.0155
166 SENSORY LOSS 125 0.0155
167 PSEUDOMONAS INFECTION 133 0.0155
168 THERMAL BURN 110 0.0155
169 RALES 90 0.0155
170 HEART RATE IRREGULAR 349 0.0154
171 BREATH SOUNDS ABNORMAL 76 0.0154
172 ACUTE RESPIRATORY FAILURE 296 0.0154
173 CYSTITIS 489 0.0153
174 DIVERTICULUM 109 0.0153
175 FEAR 412 0.0153
176 RIB FRACTURE 315 0.0153
177 RESPIRATORY DEPRESSION 187 0.0152
178 STAPHYLOCOCCAL INFECTION 502 0.0152
179 NERVE INJURY 169 0.0152
180 ECCHYMOSIS 103 0.0150
181 SLEEP APNOEA SYNDROME 285 0.0149
182 VARICOSE VEIN 77 0.0149
183 MYDRIASIS 191 0.0149
184 PROCEDURAL COMPLICATION 114 0.0149
185 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 254 0.0148
186 HEART RATE DECREASED 519 0.0148
187 COMPRESSION FRACTURE 79 0.0147
188 TROPONIN INCREASED 112 0.0147
189 ARTHROPOD BITE 109 0.0147
190 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 130 0.0147
191 ARRHYTHMIA 692 0.0146
192 NEUROTOXICITY 256 0.0146
193 FOOD ALLERGY 112 0.0145
194 ENDOPHTHALMITIS 87 0.0145
195 APPLICATION SITE VESICLES 94 0.0145
196 POST PROCEDURAL COMPLICATION 277 0.0144
197 CELLULITIS 723 0.0143
198 LEFT VENTRICULAR DYSFUNCTION 96 0.0143
199 HYPOAESTHESIA ORAL 216 0.0143
200 PHARYNGITIS 177 0.0143
201 CIRCULATORY COLLAPSE 243 0.0143
202 LOCALISED INFECTION 345 0.0143
203 EXOSTOSIS 130 0.0142
204 URINARY TRACT INFECTION 2427 0.0142
205 POST PROCEDURAL INFECTION 115 0.0141
206 HIATUS HERNIA 182 0.0140
207 ECONOMIC PROBLEM 213 0.0140
208 CANDIDA INFECTION 236 0.0140
209 BRONCHOSPASM 199 0.0139
210 DEVICE OCCLUSION 196 0.0139
211 PULMONARY HYPERTENSION 290 0.0139
212 ACUTE PULMONARY OEDEMA 78 0.0139
213 MUSCULOSKELETAL CHEST PAIN 215 0.0139
214 HYPERAESTHESIA 114 0.0139
215 FIBROMYALGIA 337 0.0138
216 BENIGN PROSTATIC HYPERPLASIA 71 0.0137
217 ATRIOVENTRICULAR BLOCK COMPLETE 92 0.0137
218 ROTATOR CUFF SYNDROME 175 0.0136
219 RENAL FAILURE 1807 0.0136
220 CARDIOMEGALY 167 0.0136
221 CONCUSSION 105 0.0135
222 SCOLIOSIS 84 0.0135
223 SKIN NECROSIS 70 0.0135
224 MENINGITIS 90 0.0135
225 RESPIRATORY TRACT CONGESTION 214 0.0135
226 TRICUSPID VALVE INCOMPETENCE 107 0.0135
227 DYSPNOEA EXERTIONAL 507 0.0134
228 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 702 0.0134
229 IRON DEFICIENCY ANAEMIA 124 0.0134
230 HAEMORRHOIDS 261 0.0134
231 INFUSION RELATED REACTION 881 0.0133
232 HAND FRACTURE 94 0.0133
233 UPPER-AIRWAY COUGH SYNDROME 109 0.0132
234 APPLICATION SITE PAIN 289 0.0131
235 APPLICATION SITE RASH 180 0.0131
236 LIMB INJURY 355 0.0131
237 SCAR 223 0.0130
238 HYPOVOLAEMIA 76 0.0130
239 BRAIN OEDEMA 164 0.0130
240 PRODUCTIVE COUGH 616 0.0129
241 DIZZINESS POSTURAL 125 0.0129
242 THERAPY PARTIAL RESPONDER 200 0.0128
243 BLOOD MAGNESIUM DECREASED 110 0.0127
244 RENAL CYST 101 0.0127
245 SINUS CONGESTION 170 0.0126
246 SCIATICA 200 0.0125
247 INTERVERTEBRAL DISC PROTRUSION 274 0.0125
248 MUSCLE STRAIN 108 0.0125
249 BLOOD UREA INCREASED 209 0.0125
250 HYPOTENSION 2502 0.0125
251 OXYGEN SATURATION DECREASED 700 0.0124
252 ILLNESS 1282 0.0124
253 RENAL TUBULAR NECROSIS 122 0.0124
254 LYMPHOEDEMA 86 0.0124
255 JOINT DISLOCATION 131 0.0124
256 CARDIAC FLUTTER 80 0.0124
257 GOUT 222 0.0124
258 COAGULOPATHY 206 0.0124
259 CARPAL TUNNEL SYNDROME 173 0.0123
260 FOOT FRACTURE 234 0.0123
261 LIGAMENT SPRAIN 122 0.0123
262 PAIN IN JAW 349 0.0123
263 INABILITY TO AFFORD MEDICATION 122 0.0123
264 MITRAL VALVE INCOMPETENCE 139 0.0123
265 FLANK PAIN 115 0.0123
266 CLOSTRIDIUM DIFFICILE COLITIS 130 0.0122
267 ARTERIOSCLEROSIS CORONARY ARTERY 81 0.0122
268 VITAMIN D DEFICIENCY 119 0.0122
269 JOINT EFFUSION 84 0.0122
270 MYOCLONUS 145 0.0121
271 ESCHERICHIA INFECTION 100 0.0121
272 INTERNATIONAL NORMALISED RATIO INCREASED 346 0.0121
273 WALKING AID USER 80 0.0121
274 SINUS HEADACHE 72 0.0121
275 IMPAIRED GASTRIC EMPTYING 165 0.0121
276 TACHYCARDIA 1074 0.0121
277 MIOSIS 97 0.0121
278 POOR QUALITY SLEEP 260 0.0121
279 EYELID PTOSIS 122 0.0120
280 ELECTROCARDIOGRAM ABNORMAL 94 0.0120
281 SPINAL COMPRESSION FRACTURE 99 0.0120
282 INCONTINENCE 126 0.0119
283 INADEQUATE ANALGESIA 101 0.0119
284 FACIAL PAIN 106 0.0119
285 RENAL FAILURE CHRONIC 91 0.0118
286 NERVE COMPRESSION 109 0.0118
287 HYPERCHOLESTEROLAEMIA 114 0.0118
288 AUTOIMMUNE DISORDER 115 0.0118
289 INJURY 828 0.0118
290 LUNG INFILTRATION 104 0.0118
291 BURSITIS 142 0.0117
292 FUNGAL INFECTION 390 0.0117
293 OSTEOPENIA 177 0.0117
294 OEDEMA 632 0.0116
295 ATRIOVENTRICULAR BLOCK 90 0.0116
296 SMALL INTESTINAL OBSTRUCTION 143 0.0116
297 COVID-19 2033 0.0116
298 NECK PAIN 647 0.0116
299 BLOOD POTASSIUM DECREASED 348 0.0116
300 MENISCUS INJURY 71 0.0115
301 IMPAIRED QUALITY OF LIFE 166 0.0115
302 COVID-19 PNEUMONIA 136 0.0115
303 JOINT INJURY 245 0.0115
304 PNEUMOTHORAX 181 0.0114
305 SENSITIVE SKIN 84 0.0114
306 FACIAL PARALYSIS 97 0.0114
307 HEART RATE INCREASED 1127 0.0114
308 GRAND MAL CONVULSION 105 0.0114
309 DRUG INTERACTION 1803 0.0114
310 OSTEOMYELITIS 205 0.0113
311 HYPOALBUMINAEMIA 88 0.0113
312 ORAL CANDIDIASIS 149 0.0113
313 SPINAL OPERATION 139 0.0113
314 CARDIOTOXICITY 100 0.0112
315 CYANOSIS 176 0.0112
316 THERAPY NON-RESPONDER 503 0.0112
317 CONTUSION 1076 0.0112
318 GLOMERULAR FILTRATION RATE DECREASED 137 0.0111
319 BACK INJURY 121 0.0111
320 JOINT RANGE OF MOTION DECREASED 149 0.0111
321 BLOOD PRESSURE DECREASED 737 0.0111
322 OBSTRUCTIVE AIRWAYS DISORDER 123 0.0110
323 BLOOD PRESSURE ABNORMAL 219 0.0110
324 PULMONARY CONGESTION 145 0.0110
325 HEREDITARY ANGIOEDEMA 118 0.0110
326 HAEMATOCRIT DECREASED 218 0.0110
327 MUSCULOSKELETAL DISCOMFORT 189 0.0110
328 ACCIDENT 131 0.0110
329 TACHYPNOEA 149 0.0109
330 PARAESTHESIA ORAL 158 0.0109
331 PULMONARY MASS 163 0.0109
332 APPLICATION SITE IRRITATION 136 0.0109
333 DYSARTHRIA 411 0.0109
334 INFLUENZA 1198 0.0107
335 PURPURA 95 0.0107
336 HERPES ZOSTER 616 0.0107
337 DEVICE FAILURE 163 0.0107
338 DRUG LEVEL INCREASED 177 0.0107
339 HAEMATOMA 277 0.0107
340 PNEUMONIA 3457 0.0107
341 SPINAL PAIN 125 0.0107
342 MALNUTRITION 119 0.0106
343 BLOOD CREATININE INCREASED 690 0.0106
344 PLEURAL EFFUSION 642 0.0105
345 EMPHYSEMA 106 0.0105
346 MICTURITION URGENCY 120 0.0105
347 PULMONARY OEDEMA 470 0.0105
348 DENTAL CARIES 116 0.0105
349 GROIN PAIN 92 0.0105
350 RENAL FAILURE ACUTE 444 0.0105
351 BLOOD ALBUMIN DECREASED 83 0.0105
352 RESPIRATION ABNORMAL 72 0.0104
353 HYPOKALAEMIA 481 0.0104
354 ANKLE FRACTURE 161 0.0104
355 BODY TEMPERATURE INCREASED 212 0.0104
356 PNEUMONIA BACTERIAL 95 0.0103
357 DIPLOPIA 268 0.0103
358 ASPIRATION 113 0.0103
359 RESPIRATORY ARREST 284 0.0103
360 EJECTION FRACTION DECREASED 160 0.0103
361 POST-TRAUMATIC STRESS DISORDER 69 0.0103
362 RIGHT VENTRICULAR FAILURE 72 0.0103
363 LYMPHOCYTE COUNT DECREASED 181 0.0102
364 OSTEOARTHRITIS 434 0.0102
365 GASTROINTESTINAL HAEMORRHAGE 854 0.0102
366 POSTOPERATIVE WOUND INFECTION 69 0.0102
367 UNEVALUABLE EVENT 771 0.0102
368 VITREOUS FLOATERS 100 0.0102
369 BACK DISORDER 165 0.0101
370 SPINAL DISORDER 96 0.0101
371 EAR PAIN 197 0.0101
372 ANAL INCONTINENCE 91 0.0101
373 UPPER GASTROINTESTINAL HAEMORRHAGE 170 0.0101
374 FEBRILE NEUTROPENIA 669 0.0101
375 MULTIPLE ORGAN DYSFUNCTION SYNDROME 285 0.0101
376 ULCER 160 0.0100
377 BLOOD CALCIUM DECREASED 113 0.0100
378 RHINITIS 81 0.0100
379 FLUID RETENTION 510 0.0100
380 MIGRAINE 954 0.0100
381 BLADDER DISORDER 99 0.0100
382 RETINAL HAEMORRHAGE 71 0.0100
383 WOUND INFECTION 109 0.0099
384 BACK PAIN 2311 0.0099
385 HYPERTHYROIDISM 144 0.0099
386 PRODUCT AVAILABILITY ISSUE 226 0.0099
387 HOSPICE CARE 98 0.0099
388 CLOSTRIDIUM DIFFICILE INFECTION 216 0.0099
389 BRAIN FOG 155 0.0099
390 SEPSIS 1100 0.0099
391 NASOPHARYNGITIS 1815 0.0098
392 IRRITABLE BOWEL SYNDROME 211 0.0098
393 DIVERTICULITIS 272 0.0098
394 BLOOD CALCIUM INCREASED 86 0.0098
395 TOXICITY TO VARIOUS AGENTS 1648 0.0098
396 MASS 136 0.0097
397 RESPIRATORY DISTRESS 268 0.0097
398 DRUG TOXICITY 132 0.0097
399 OEDEMA PERIPHERAL 1181 0.0097
400 LACERATION 91 0.0097
401 TOOTH FRACTURE 106 0.0096
402 APPLICATION SITE ERYTHEMA 252 0.0096
403 CARDIAC FAILURE CONGESTIVE 772 0.0096
404 SCRATCH 101 0.0096
405 HAEMOPTYSIS 267 0.0096
406 ELECTROLYTE IMBALANCE 111 0.0095
407 PULMONARY FIBROSIS 183 0.0095
408 PELVIC FRACTURE 74 0.0095
409 TOOTH DISORDER 211 0.0095
410 HYPOMAGNESAEMIA 132 0.0095
411 ACUTE KIDNEY INJURY 1450 0.0095
412 BRAIN INJURY 95 0.0095
413 HEAD INJURY 299 0.0094
414 BACTERAEMIA 112 0.0094
415 RESPIRATORY FAILURE 688 0.0094
416 SPINAL FRACTURE 189 0.0094
417 EPISTAXIS 705 0.0094
418 PNEUMONIA ASPIRATION 235 0.0094
419 DEVICE PHYSICAL PROPERTY ISSUE 72 0.0094
420 NEPHROLITHIASIS 431 0.0094
421 INTERNAL HAEMORRHAGE 107 0.0094
422 INFECTION 1355 0.0094
423 PARALYSIS 134 0.0094
424 DEVICE RELATED INFECTION 143 0.0093
425 WRIST FRACTURE 111 0.0093
426 PALPITATIONS 1084 0.0092
427 PULMONARY ARTERIAL HYPERTENSION 134 0.0092
428 APHONIA 129 0.0092
429 RESPIRATORY DISORDER 276 0.0092
430 MOTOR DYSFUNCTION 94 0.0092
431 PALLOR 251 0.0092
432 SWELLING 863 0.0092
433 GASTROOESOPHAGEAL REFLUX DISEASE 739 0.0092
434 BLOOD SODIUM DECREASED 173 0.0092
435 SPUTUM DISCOLOURED 87 0.0092
436 TOOTHACHE 166 0.0092
437 ASCITES 269 0.0091
438 CONJUNCTIVITIS 169 0.0091
439 UROSEPSIS 84 0.0091
440 NEPHROPATHY 85 0.0091
441 OSTEOPOROSIS 374 0.0091
442 FALL 3024 0.0091
443 PERICARDIAL EFFUSION 210 0.0091
444 ENCEPHALOPATHY 223 0.0091
445 ORAL PAIN 203 0.0091
446 LEUKOCYTOSIS 164 0.0091
447 CATARACT 539 0.0090
448 ATAXIA 107 0.0090
449 PROCEDURAL PAIN 250 0.0090
450 BLOOD URINE PRESENT 171 0.0090
451 PRESYNCOPE 219 0.0090
452 CARDIO-RESPIRATORY ARREST 376 0.0090
453 LOSS OF CONSCIOUSNESS 1150 0.0090
454 POST PROCEDURAL HAEMORRHAGE 104 0.0089
455 COUGH 2497 0.0089
456 PRODUCT DOSE OMISSION ISSUE 2618 0.0089
457 PHARYNGEAL SWELLING 87 0.0089
458 LUNG INFECTION 138 0.0089
459 OESOPHAGITIS 97 0.0089
460 CARDIOMYOPATHY 131 0.0089
461 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1596 0.0088
462 CHILLS 1038 0.0088
463 EXPIRED PRODUCT ADMINISTERED 294 0.0088
464 ARTERIOSCLEROSIS 83 0.0088
465 MYOSITIS 79 0.0088
466 RESPIRATORY RATE INCREASED 78 0.0088
467 DYSPNOEA 4968 0.0088
468 BLOOD IRON DECREASED 104 0.0088
469 BLOOD POTASSIUM INCREASED 142 0.0087
470 OROPHARYNGEAL PAIN 806 0.0087
471 RESTLESS LEGS SYNDROME 158 0.0087
472 RECTAL HAEMORRHAGE 372 0.0087
473 PAIN 5304 0.0086
474 COLD SWEAT 152 0.0086
475 NASAL CONGESTION 504 0.0086
476 SKIN ULCER 221 0.0085
477 URINARY INCONTINENCE 253 0.0085
478 HYPONATRAEMIA 478 0.0085
479 TUBULOINTERSTITIAL NEPHRITIS 159 0.0085
480 LETHARGY 488 0.0085
481 TRANSIENT ISCHAEMIC ATTACK 286 0.0085
482 CHEST DISCOMFORT 868 0.0085
483 SUBARACHNOID HAEMORRHAGE 86 0.0084
484 SEROTONIN SYNDROME 162 0.0084
485 VITAMIN D DECREASED 72 0.0084
486 DELIRIUM 292 0.0084
487 HAEMATURIA 288 0.0084
488 BLOOD PRESSURE INCREASED 1282 0.0084
489 CHEST PAIN 1553 0.0084
490 SECRETION DISCHARGE 105 0.0084
491 HEMIPARESIS 142 0.0084
492 ARTHRITIS 658 0.0084
493 BURNING SENSATION 586 0.0083
494 NODULE 109 0.0083
495 ORAL HERPES 163 0.0083
496 GINGIVAL BLEEDING 114 0.0083
497 SHOCK 192 0.0083
498 SYNCOPE 831 0.0083
499 CARDIAC DISORDER 777 0.0083
500 NEUROPATHY PERIPHERAL 788 0.0083
501 CHROMATURIA 187 0.0083
502 UPPER LIMB FRACTURE 165 0.0083
503 PULMONARY THROMBOSIS 90 0.0082
504 HYPERTENSION 1747 0.0082
505 ROAD TRAFFIC ACCIDENT 345 0.0082
506 THYROID DISORDER 127 0.0082
507 URINE OUTPUT DECREASED 72 0.0082
508 BONE DISORDER 150 0.0082
509 ABSCESS 131 0.0082
510 CARDIAC MURMUR 71 0.0082
511 NEUTROPHIL COUNT INCREASED 84 0.0082
512 SEIZURE 947 0.0082
513 DYSPHAGIA 776 0.0082
514 WHEEZING 484 0.0082
515 METABOLIC ACIDOSIS 261 0.0082
516 DISABILITY 161 0.0081
517 URINARY RETENTION 269 0.0081
518 INCREASED TENDENCY TO BRUISE 74 0.0080
519 ACCIDENTAL OVERDOSE 294 0.0080
520 MUSCLE TWITCHING 185 0.0080
521 MUSCULAR WEAKNESS 911 0.0080
522 CYST 99 0.0080
523 ILEUS 99 0.0080
524 ANXIETY 2264 0.0079
525 LIMB DISCOMFORT 246 0.0079
526 HEADACHE 4978 0.0079
527 RENAL PAIN 84 0.0079
528 MUSCULOSKELETAL PAIN 415 0.0079
529 GENERALISED OEDEMA 98 0.0079
530 GASTRITIS 207 0.0079
531 ABDOMINAL DISTENSION 820 0.0078
532 HYPERKALAEMIA 275 0.0078
533 WEIGHT DECREASED 2188 0.0078
534 HIP FRACTURE 252 0.0078
535 HEPATOMEGALY 77 0.0078
536 CYTOKINE RELEASE SYNDROME 157 0.0078
537 ANAEMIA 1490 0.0078
538 CARDIAC FAILURE 627 0.0078
539 MACULAR DEGENERATION 93 0.0078
540 HYPOAESTHESIA 1164 0.0078
541 PETECHIAE 81 0.0078
542 DEHYDRATION 1035 0.0078
543 HERNIA 150 0.0077
544 OROPHARYNGEAL DISCOMFORT 70 0.0077
545 PERIPHERAL SWELLING 1192 0.0077
546 DYSURIA 284 0.0077
547 LYMPHADENOPATHY 273 0.0077
548 PHOTOPHOBIA 145 0.0077
549 LOWER RESPIRATORY TRACT INFECTION 350 0.0077
550 DYSPHONIA 449 0.0077
551 RED BLOOD CELL COUNT DECREASED 219 0.0077
552 LOWER LIMB FRACTURE 147 0.0076
553 CONSTIPATION 1668 0.0076
554 SKIN DISORDER 255 0.0076
555 HIP ARTHROPLASTY 117 0.0076
556 BLISTER 428 0.0076
557 DIZZINESS 3798 0.0076
558 FATIGUE 5909 0.0076
559 FEELING COLD 211 0.0076
560 ASTHMA 856 0.0076
561 HYPOTHYROIDISM 241 0.0075
562 MUSCLE TIGHTNESS 122 0.0075
563 ASPARTATE AMINOTRANSFERASE INCREASED 400 0.0075
564 LUNG DISORDER 369 0.0075
565 WOUND 210 0.0075
566 PHOTOSENSITIVITY REACTION 124 0.0075
567 GASTROINTESTINAL DISORDER 672 0.0075
568 EYE HAEMORRHAGE 100 0.0075
569 MUSCLE SPASTICITY 92 0.0075
570 PYREXIA 2590 0.0075
571 OCULAR DISCOMFORT 84 0.0075
572 SUBDURAL HAEMATOMA 107 0.0075
573 DISCOMFORT 456 0.0075
574 DERMATITIS ALLERGIC 94 0.0075
575 EATING DISORDER 159 0.0075
576 SCAB 85 0.0074
577 BLOOD PRESSURE FLUCTUATION 178 0.0074
578 EAR DISCOMFORT 76 0.0074
579 BLOOD TEST ABNORMAL 104 0.0074
580 BLOOD CHOLESTEROL INCREASED 345 0.0074
581 FULL BLOOD COUNT ABNORMAL 78 0.0074
582 PREMATURE DELIVERY 117 0.0073
583 EYE INFLAMMATION 70 0.0073
584 PAIN IN EXTREMITY 2161 0.0073
585 HYPOTONIA 73 0.0073
586 IMPAIRED HEALING 240 0.0073
587 DEPRESSED LEVEL OF CONSCIOUSNESS 289 0.0073
588 COMPLICATION ASSOCIATED WITH DEVICE 106 0.0073
589 MYOCARDIAL ISCHAEMIA 83 0.0073
590 HYPOACUSIS 313 0.0073
591 RENAL IMPAIRMENT 609 0.0072
592 OBESITY 115 0.0072
593 FOOT DEFORMITY 80 0.0072
594 FLUID OVERLOAD 105 0.0072
595 IMPAIRED DRIVING ABILITY 82 0.0072
596 MOUTH ULCERATION 152 0.0072
597 INCORRECT PRODUCT ADMINISTRATION DURATION 156 0.0072
598 TINNITUS 330 0.0072
599 RHINORRHOEA 464 0.0072
600 HALLUCINATION, VISUAL 151 0.0071
601 DRY MOUTH 580 0.0071
602 CONFUSIONAL STATE 1155 0.0071
603 STOMATITIS 433 0.0071
604 SKIN DISCOLOURATION 328 0.0071
605 VERTIGO 435 0.0071
606 BLOOD ALKALINE PHOSPHATASE INCREASED 177 0.0071
607 BLOOD BILIRUBIN INCREASED 192 0.0071
608 SUDDEN DEATH 75 0.0071
609 APHASIA 214 0.0071
610 THROMBOSIS 568 0.0071
611 GALLBLADDER DISORDER 126 0.0071
612 TOXIC EPIDERMAL NECROLYSIS 107 0.0070
613 HEPATIC STEATOSIS 131 0.0070
614 TREMOR 1166 0.0070
615 NAUSEA 5530 0.0070
616 NIGHT SWEATS 225 0.0070
617 ASTHENIA 2624 0.0070
618 LIP SWELLING 232 0.0070
619 APPLICATION SITE PRURITUS 158 0.0070
620 BALANCE DISORDER 601 0.0069
621 DECREASED ACTIVITY 75 0.0069
622 SOMNOLENCE 1398 0.0069
623 RESTLESSNESS 254 0.0069
624 BEDRIDDEN 91 0.0069
625 ALANINE AMINOTRANSFERASE INCREASED 425 0.0069
626 HYPERTENSIVE CRISIS 77 0.0069
627 SNEEZING 155 0.0069
628 WHITE BLOOD CELL COUNT INCREASED 265 0.0069
629 ACUTE RESPIRATORY DISTRESS SYNDROME 122 0.0069
630 MUSCLE SPASMS 1265 0.0069
631 BASAL CELL CARCINOMA 107 0.0069
632 MUSCLE RIGIDITY 82 0.0068
633 GLAUCOMA 132 0.0068
634 NERVOUSNESS 358 0.0068
635 SEPTIC SHOCK 298 0.0068
636 LIVER FUNCTION TEST INCREASED 147 0.0068
637 TENDONITIS 106 0.0068
638 PRODUCT USE IN UNAPPROVED INDICATION 1690 0.0068
639 INTENTIONAL PRODUCT USE ISSUE 597 0.0068
640 TENDON RUPTURE 84 0.0068
641 RETCHING 145 0.0068
642 FULL BLOOD COUNT DECREASED 137 0.0068
643 GAIT DISTURBANCE 1301 0.0068
644 SURGERY 398 0.0068
645 SLEEP DISORDER 479 0.0068
646 QUALITY OF LIFE DECREASED 91 0.0068
647 SPEECH DISORDER 355 0.0068
648 HYPERSOMNIA 194 0.0068
649 HYPOCALCAEMIA 128 0.0068
650 INFLUENZA LIKE ILLNESS 556 0.0067
651 OFF LABEL USE 5890 0.0067
652 SWOLLEN TONGUE 210 0.0067
653 MUSCLE ATROPHY 85 0.0067
654 TASTE DISORDER 136 0.0067
655 VOMITING 3151 0.0067
656 HYPERHIDROSIS 860 0.0067
657 ACTIVITIES OF DAILY LIVING IMPAIRED 132 0.0067
658 DECREASED APPETITE 1545 0.0066
659 DISORIENTATION 263 0.0066
660 EYE PAIN 373 0.0066
661 NOCTURIA 80 0.0066
662 PREMATURE BABY 198 0.0066
663 KNEE ARTHROPLASTY 138 0.0065
664 ACUTE MYOCARDIAL INFARCTION 193 0.0065
665 PRODUCT USE COMPLAINT 103 0.0065
666 WEIGHT INCREASED 1463 0.0065
667 DYSSTASIA 190 0.0065
668 INTRAOCULAR PRESSURE INCREASED 83 0.0065
669 JOINT STIFFNESS 170 0.0065
670 CHOLECYSTECTOMY 74 0.0065
671 ARTHROPATHY 360 0.0065
672 PRODUCT USE ISSUE 1217 0.0065
673 CHOLECYSTITIS 77 0.0065
674 RASH PRURITIC 350 0.0065
675 ANGINA PECTORIS 184 0.0064
676 BLINDNESS 261 0.0064
677 CHOLELITHIASIS 210 0.0064
678 BONE PAIN 375 0.0064
679 DEAFNESS 167 0.0064
680 COMA 304 0.0064
681 NERVOUS SYSTEM DISORDER 199 0.0064
682 ORTHOSTATIC HYPOTENSION 111 0.0064
683 IMPAIRED WORK ABILITY 136 0.0064
684 BLOOD PRESSURE SYSTOLIC INCREASED 124 0.0064
685 DRUG INTOLERANCE 614 0.0063
686 RENAL DISORDER 296 0.0063
687 DYSPEPSIA 623 0.0063
688 MUCOSAL INFLAMMATION 165 0.0063
689 NEOPLASM 72 0.0063
690 HAEMOGLOBIN DECREASED 643 0.0063
691 PULMONARY EMBOLISM 595 0.0063
692 PRODUCT DOSE OMISSION IN ERROR 177 0.0062
693 URTICARIA 1046 0.0062
694 EMOTIONAL DISTRESS 755 0.0062
695 SEDATION 163 0.0062
696 NEEDLE ISSUE 181 0.0062
697 FEEDING DISORDER 126 0.0062
698 CORONARY ARTERY DISEASE 188 0.0062
699 DIARRHOEA 4007 0.0062
700 PARAESTHESIA 976 0.0062
701 DYSKINESIA 252 0.0062
702 ERYTHEMA 1272 0.0062
703 TOOTH EXTRACTION 77 0.0062
704 SWELLING FACE 402 0.0062
705 ANGIOEDEMA 273 0.0062
706 GAIT INABILITY 206 0.0062
707 HEAD DISCOMFORT 109 0.0062
708 THIRST 110 0.0062
709 FEELING ABNORMAL 1475 0.0061
710 VISUAL ACUITY REDUCED 204 0.0061
711 PRODUCT ADMINISTRATION ERROR 124 0.0061
712 INSOMNIA 1632 0.0061
713 ABDOMINAL PAIN 1424 0.0061
714 PERIPHERAL COLDNESS 84 0.0061
715 HAEMORRHAGE 639 0.0061
716 PRODUCT PRESCRIBING ERROR 145 0.0061
717 MALAISE 2665 0.0061
718 TRANSAMINASES INCREASED 135 0.0061
719 HEPATOCELLULAR INJURY 86 0.0061
720 NO ADVERSE EVENT 1095 0.0060
721 DISSEMINATED INTRAVASCULAR COAGULATION 85 0.0060
722 DIABETES MELLITUS 460 0.0060
723 AGITATION 443 0.0060
724 ADRENAL INSUFFICIENCY 73 0.0060
725 HYPERSENSITIVITY 1116 0.0060
726 MEDICATION ERROR 334 0.0060
727 DEVICE DISLOCATION 261 0.0060
728 NEUTROPHIL COUNT DECREASED 244 0.0060
729 AMNESIA 389 0.0060
730 ARTHRALGIA 2484 0.0060
731 ABDOMINAL DISCOMFORT 999 0.0059
732 THROAT IRRITATION 267 0.0059
733 SKIN CANCER 128 0.0059
734 PLATELET COUNT DECREASED 633 0.0059
735 RASH MACULO-PAPULAR 132 0.0059
736 CORONARY ARTERY OCCLUSION 81 0.0059
737 FAECES DISCOLOURED 128 0.0059
738 DEPRESSION 1343 0.0059
739 JOINT SWELLING 712 0.0059
740 GASTRIC ULCER 112 0.0059
741 VISION BLURRED 808 0.0059
742 MELAENA 129 0.0059
743 MENTAL IMPAIRMENT 142 0.0059
744 HYPOKINESIA 85 0.0058
745 HYPERCALCAEMIA 72 0.0058
746 MEMORY IMPAIRMENT 801 0.0058
747 EXPOSURE DURING PREGNANCY 362 0.0058
748 DEEP VEIN THROMBOSIS 378 0.0058
749 ALTERED STATE OF CONSCIOUSNESS 126 0.0058
750 LIVER FUNCTION TEST ABNORMAL 169 0.0058
751 POISONING 73 0.0058
752 COLITIS 220 0.0058
753 MYALGIA 985 0.0058
754 DYSTONIA 112 0.0058
755 ORAL DISCOMFORT 80 0.0058
756 POLLAKIURIA 239 0.0057
757 THROAT TIGHTNESS 154 0.0057
758 PNEUMONITIS 155 0.0057
759 DRUG INEFFECTIVE 7501 0.0057
760 METASTASES TO BONE 93 0.0057
761 SKIN LESION 155 0.0056
762 THERAPEUTIC RESPONSE UNEXPECTED 253 0.0056
763 DEMENTIA 157 0.0056
764 IMMUNE SYSTEM DISORDER 74 0.0056
765 CONDITION AGGRAVATED 1707 0.0056
766 CONVULSION 321 0.0056
767 MENTAL DISORDER 244 0.0056
768 RASH 2436 0.0056
769 INTENTIONAL PRODUCT MISUSE 489 0.0056
770 HALLUCINATION 419 0.0056
771 MUSCULOSKELETAL STIFFNESS 487 0.0056
772 HAIR COLOUR CHANGES 69 0.0055
773 HAIR TEXTURE ABNORMAL 74 0.0055
774 BONE DENSITY DECREASED 173 0.0055
775 RASH MACULAR 193 0.0055
776 HEPATIC FAILURE 164 0.0054
777 HYPOPHAGIA 139 0.0054
778 SENSORY DISTURBANCE 87 0.0054
779 GAMMA-GLUTAMYLTRANSFERASE INCREASED 120 0.0054
780 CEREBROVASCULAR ACCIDENT 917 0.0054
781 FLUSHING 550 0.0054
782 BLOOD COUNT ABNORMAL 82 0.0054
783 FLATULENCE 306 0.0054
784 FEELING HOT 330 0.0054
785 COGNITIVE DISORDER 251 0.0054
786 RASH PAPULAR 120 0.0053
787 HAEMORRHAGE INTRACRANIAL 80 0.0053
788 C-REACTIVE PROTEIN INCREASED 194 0.0053
789 DRUG EFFECT LESS THAN EXPECTED 79 0.0053
790 SKIN HAEMORRHAGE 79 0.0053
791 MATERNAL EXPOSURE DURING PREGNANCY 474 0.0053
792 DISTURBANCE IN ATTENTION 286 0.0053
793 SARS-COV-2 TEST POSITIVE 70 0.0053
794 INTENTIONAL DOSE OMISSION 151 0.0053
795 PRODUCT PRESCRIBING ISSUE 115 0.0053
796 RASH ERYTHEMATOUS 252 0.0053
797 PRURITUS 2022 0.0053
798 THINKING ABNORMAL 98 0.0053
799 DERMATITIS 110 0.0052
800 ABDOMINAL PAIN UPPER 1080 0.0052
801 MOBILITY DECREASED 376 0.0052
802 IMMUNODEFICIENCY 78 0.0052
803 WHITE BLOOD CELL COUNT DECREASED 567 0.0052
804 FACE OEDEMA 88 0.0052
805 INFLAMMATION 269 0.0052
806 TOOTH LOSS 108 0.0052
807 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 370 0.0052
808 VISUAL IMPAIRMENT 643 0.0052
809 SKIN REACTION 73 0.0052
810 PSYCHOMOTOR HYPERACTIVITY 86 0.0052
811 LACRIMATION INCREASED 156 0.0052
812 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 248 0.0052
813 LOCAL SWELLING 90 0.0052
814 BLOOD TRIGLYCERIDES INCREASED 91 0.0051
815 MUSCULOSKELETAL DISORDER 98 0.0051
816 INTESTINAL OBSTRUCTION 194 0.0051
817 PHARYNGEAL OEDEMA 79 0.0051
818 AGEUSIA 128 0.0051
819 PRESCRIBED OVERDOSE 99 0.0051
820 HEPATIC CIRRHOSIS 96 0.0051
821 WRONG TECHNIQUE IN DRUG USAGE PROCESS 185 0.0051
822 PERICARDITIS 85 0.0051
823 ACUTE HEPATIC FAILURE 69 0.0050
824 PANCYTOPENIA 281 0.0050
825 PLASMA CELL MYELOMA 196 0.0050
826 COORDINATION ABNORMAL 70 0.0050
827 MIDDLE INSOMNIA 93 0.0050
828 DRY EYE 248 0.0050
829 BLINDNESS UNILATERAL 70 0.0050
830 ABASIA 122 0.0049
831 PARANOIA 85 0.0049
832 OSTEONECROSIS OF JAW 121 0.0049
833 CEREBRAL HAEMORRHAGE 175 0.0049
834 PANIC ATTACK 178 0.0049
835 FEELING JITTERY 93 0.0049
836 HEPATIC ENZYME INCREASED 326 0.0048
837 GASTRIC DISORDER 163 0.0047
838 EYE DISORDER 156 0.0047
839 PELVIC PAIN 85 0.0047
840 DRUG EFFECT INCOMPLETE 169 0.0046
841 GENERAL PHYSICAL HEALTH DETERIORATION 535 0.0046
842 HOT FLUSH 347 0.0046
843 THROMBOCYTOPENIA 513 0.0046
844 HAEMATEMESIS 116 0.0046
845 INCORRECT DRUG ADMINISTRATION DURATION 128 0.0045
846 DRUG EFFECT DECREASED 243 0.0045
847 CHOKING 88 0.0045
848 DELUSION 70 0.0045
849 OVERDOSE 969 0.0045
850 HAEMATOCHEZIA 247 0.0045
851 PRODUCT PHYSICAL ISSUE 90 0.0045
852 HOSPITALISATION 682 0.0044
853 SYSTEMIC LUPUS ERYTHEMATOSUS 157 0.0044
854 EYE SWELLING 164 0.0044
855 DEVICE LEAKAGE 190 0.0044
856 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 884 0.0044
857 DYSGEUSIA 324 0.0044
858 ERUCTATION 84 0.0043
859 FEMUR FRACTURE 134 0.0043
860 MULTIPLE FRACTURES 71 0.0043
861 STEVENS-JOHNSON SYNDROME 96 0.0043
862 TREATMENT FAILURE 357 0.0043
863 PREGNANCY 86 0.0043
864 LABORATORY TEST ABNORMAL 126 0.0043
865 HYPERGLYCAEMIA 155 0.0042
866 EMOTIONAL DISORDER 131 0.0042
867 GLOSSODYNIA 95 0.0042
868 THERAPY INTERRUPTED 303 0.0042
869 JAUNDICE 114 0.0042
870 DRUG ERUPTION 75 0.0042
871 DRUG ABUSE 352 0.0042
872 LIVER DISORDER 186 0.0042
873 TYPE 2 DIABETES MELLITUS 141 0.0042
874 PRODUCT PREPARATION ERROR 86 0.0042
875 CRYING 152 0.0042
876 MOVEMENT DISORDER 134 0.0042
877 LIVER INJURY 102 0.0042
878 INCORRECT ROUTE OF DRUG ADMINISTRATION 148 0.0041
879 THERAPEUTIC RESPONSE DECREASED 251 0.0041
880 NEOPLASM MALIGNANT 276 0.0041
881 DRUG ADMINISTRATION ERROR 126 0.0041
882 ALOPECIA 804 0.0041
883 ISCHAEMIC STROKE 73 0.0041
884 PRODUCT DISPENSING ERROR 89 0.0041
885 RHEUMATOID ARTHRITIS 460 0.0040
886 DEVICE ISSUE 363 0.0040
887 PRURITUS GENERALISED 87 0.0040
888 OSTEONECROSIS 132 0.0040
889 DEPRESSED MOOD 212 0.0040
890 THERAPEUTIC PRODUCT EFFECT DECREASED 179 0.0040
891 CONTRAINDICATED PRODUCT ADMINISTERED 121 0.0040
892 INCREASED APPETITE 76 0.0040
893 PANCREATITIS 210 0.0040
894 SUICIDAL IDEATION 361 0.0039
895 RHABDOMYOLYSIS 161 0.0039
896 BLOOD GLUCOSE DECREASED 185 0.0038
897 BLOOD GLUCOSE ABNORMAL 71 0.0038
898 SKIN EXFOLIATION 324 0.0038
899 WITHDRAWAL SYNDROME 161 0.0038
900 SYNOVITIS 69 0.0038
901 ABNORMAL DREAMS 105 0.0038
902 TREATMENT NONCOMPLIANCE 207 0.0038
903 PRODUCT SUBSTITUTION ISSUE 217 0.0038
904 HYPOGLYCAEMIA 182 0.0037
905 NEUTROPENIA 509 0.0037
906 ADVERSE DRUG REACTION 336 0.0037
907 THERAPY CESSATION 192 0.0037
908 MYOCARDIAL INFARCTION 651 0.0037
909 ABDOMINAL PAIN LOWER 94 0.0037
910 OCULAR HYPERAEMIA 176 0.0037
911 PRODUCT DOSE OMISSION 242 0.0037
912 RASH GENERALISED 96 0.0037
913 MOOD ALTERED 101 0.0037
914 DISEASE PROGRESSION 438 0.0037
915 INTERSTITIAL LUNG DISEASE 179 0.0037
916 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 86 0.0037
917 SKIN FISSURES 72 0.0037
918 BLOOD CREATINE PHOSPHOKINASE INCREASED 106 0.0037
919 HEPATITIS 94 0.0037
920 NIGHTMARE 126 0.0036
921 PROTEINURIA 69 0.0036
922 INJECTION SITE SWELLING 276 0.0036
923 DEATH 3091 0.0036
924 DEVICE USE ERROR 123 0.0035
925 SKIN IRRITATION 162 0.0035
926 MALIGNANT NEOPLASM PROGRESSION 362 0.0035
927 LEUKOPENIA 176 0.0035
928 ECZEMA 183 0.0035
929 NEOPLASM PROGRESSION 120 0.0034
930 EYE IRRITATION 198 0.0034
931 IRRITABILITY 206 0.0034
932 FREQUENT BOWEL MOVEMENTS 91 0.0034
933 PSYCHOTIC DISORDER 99 0.0033
934 INCORRECT DOSE ADMINISTERED 761 0.0033
935 PSORIATIC ARTHROPATHY 134 0.0033
936 DRUG-INDUCED LIVER INJURY 103 0.0033
937 PHARMACEUTICAL PRODUCT COMPLAINT 85 0.0033
938 INJECTION SITE MASS 121 0.0033
939 INJECTION SITE PAIN 1000 0.0033
940 EXTRA DOSE ADMINISTERED 132 0.0033
941 EYE PRURITUS 108 0.0032
942 ILL-DEFINED DISORDER 194 0.0032
943 EPILEPSY 97 0.0032
944 LACTIC ACIDOSIS 101 0.0031
945 CARDIOVASCULAR DISORDER 79 0.0031
946 PAIN OF SKIN 83 0.0031
947 CEREBRAL INFARCTION 75 0.0031
948 INJECTION SITE ERYTHEMA 380 0.0031
949 DISEASE RECURRENCE 145 0.0030
950 DEVICE MALFUNCTION 214 0.0030
951 ABNORMAL BEHAVIOUR 120 0.0030
952 HEPATIC FUNCTION ABNORMAL 113 0.0030
953 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 212 0.0030
954 FOETAL EXPOSURE DURING PREGNANCY 242 0.0030
955 BLOOD GLUCOSE INCREASED 550 0.0029
956 ADVERSE EVENT 269 0.0029
957 INTENTIONAL OVERDOSE 186 0.0029
958 THERAPEUTIC RESPONSE SHORTENED 96 0.0029
959 VAGINAL HAEMORRHAGE 125 0.0029
960 GLYCOSYLATED HAEMOGLOBIN INCREASED 72 0.0028
961 INJECTION SITE PRURITUS 191 0.0028
962 MULTIPLE SCLEROSIS 136 0.0028
963 DRY SKIN 378 0.0028
964 INJECTION SITE REACTION 194 0.0028
965 AGGRESSION 139 0.0028
966 INJECTION SITE BRUISING 220 0.0028
967 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 79 0.0027
968 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 88 0.0026
969 ANGER 88 0.0026
970 DRUG DOSE OMISSION 418 0.0025
971 UNDERDOSE 182 0.0025
972 LUNG NEOPLASM MALIGNANT 102 0.0025
973 ACCIDENTAL EXPOSURE TO PRODUCT 253 0.0025
974 MOOD SWINGS 78 0.0024
975 TARDIVE DYSKINESIA 69 0.0024
976 DEVICE BREAKAGE 97 0.0024
977 SKIN BURNING SENSATION 171 0.0024
978 INJECTION SITE RASH 69 0.0022
979 MULTIPLE SCLEROSIS RELAPSE 154 0.0022
980 DRUG WITHDRAWAL SYNDROME 197 0.0022
981 COMPLETED SUICIDE 186 0.0022
982 DEVICE DIFFICULT TO USE 146 0.0022
983 SUICIDE ATTEMPT 132 0.0022
984 INJECTION SITE HAEMORRHAGE 168 0.0021
985 PSORIASIS 261 0.0020
986 COLITIS ULCERATIVE 84 0.0019
987 DRUG DEPENDENCE 276 0.0017
988 BREAST CANCER 148 0.0016
989 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 73 0.0016
990 DERMATITIS ATOPIC 79 0.0015
991 ACNE 113 0.0015
992 PRODUCT STORAGE ERROR 118 0.0013
993 PROSTATE CANCER 81 0.0010